This Biomarker Research thematic series is currently open for submissions. Research studies and reviews on biomarkers for diagnosis, prognosis, and targeted therapy for cancer immunotherapy are welcome to the series. Novel and/or major advances in methodologies and materials for biomarker research will be also be considered.
To ensure publication in 2021, the submission deadline for all manuscripts is September 30. Submissions should be made via the journal's Editorial Manager.